Drugs / Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules
Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07233889 | Nov 2025 → May 2026 overdue | hypophosphatemia | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07233889 ↗ |
| Route | Oral | “Participants with hypophosphatemia will receive Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules orally or via nasogastric tube” NCT07233889 ↗ |
| Route | Other | “Participants with hypophosphatemia will receive Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules orally or via nasogastric tube” NCT07233889 ↗ |